Cancer statistics, 2016
2016/01/01 by Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · 55 citations
Medicine · Economics, Econometrics and Finance · #Global Cancer Incidence and Screening #Colorectal Cancer Screening and Detection #Economic and Financial Impacts of Cancer
paper · doi:10.3322/caac.21332
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States. Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009-2012), much of which is because of recent rapid declines in prostate cancer diagnoses. The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012. Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease. Among children and adolescents (aged birth-19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia. Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population.
Cited by
- Cancer treatment and survivorship statistics, 2016
- An update on larynx cancer
- American Cancer Society Head and Neck Cancer Survivorship Care Guideline
- <i>Fusobacterium nucleatum</i> impairs <scp>DNA</scp> mismatch repair and stability in patients with squamous cell carcinoma of the head and neck
- Real-time differentiation of adenomatous and hyperplastic diminutive colorectal polyps during analysis of unaltered videos of standard colonoscopy using a deep learning model
- LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR‐128/CD151 pathway in hepatocellular carcinoma
- The small molecule AU14022 promotes colorectal cancer cell death via p53‐mediated G2/M‐phase arrest and mitochondria‐mediated apoptosis
- Development and Validation of Novel Dietary and Lifestyle Inflammation Scores
- Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer
- Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trial
- Outcomes Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder in Patients Refusing Radical Cystectomy
- The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer
- Enhanced real-time pose estimation for closed-loop robotic manipulation of magnetically actuated capsule endoscopes
- Classification of Epithelial Ovarian Carcinoma Whole-Slide Pathology Images Using Deep Transfer Learning
- miR‐190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma
- Shifted Golgi targeting of glycosyltransferases and α-mannosidase IA from giantin to GM130-GRASP65 results in formation of high mannose N -glycans in aggressive prostate cancer cells
- Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors
- Adaptation of a deep learning malignancy model from full-field digital mammography to digital breast tomosynthesis
- Re:Opening up data at the European Medicines Agency
- Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer
- Pension Reforms in EU Member States: progress and Challenges
- Association between Outdoor Air Pollution and Childhood Leukemia: A Systematic Review and Dose–Response Meta-Analysis
- Gold nanoparticle-assisted enhancement in the anti-cancer properties of theaflavin against human ovarian cancer cells
- Computer-aided diagnosis of endobronchial ultrasound images using convolutional neural network
- miR‐938 promotes cell proliferation by regulating RBM5 in lung adenocarcinoma cells
- RETRACTED: Molecular targets for the management of cancer using Curcuma longa Linn. phytoconstituents: A Review
- Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guideline Recommendations
- Phosphatidylserine: A cancer cell targeting biomarker
- A Hypersensitive Breast Cancer Detector
- Use of Alternative Medicine for Cancer and Its Impact on Survival
- Global Burden of Urologic Cancers, 1990–2013
- Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. [europepmc]
- Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial. [europepmc]
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. [europepmc]
- Ovarian cancer. [europepmc]
- Integrated genomic characterization of oesophageal carcinoma. [europepmc]
- Multiple myeloma epidemiology and survival: A unique malignancy. [europepmc]
- Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. [europepmc]
- Renal cell carcinoma. [europepmc]
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. [europepmc]
- Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. [europepmc]
- Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. [europepmc]
- Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer. [europepmc]
- KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer. [europepmc]
- Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. [europepmc]
- Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer. [europepmc]
- The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. [europepmc]
- NCCN Guidelines Insights: Colon Cancer, Version 2.2018. [europepmc]
- Current Challenges and Opportunities in Treating Glioblastoma. [europepmc]
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. [europepmc]
- IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. [europepmc]
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. [europepmc]
- Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. [europepmc]
- Curcumin and Cancer. [europepmc]
- Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. [europepmc]
- Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. [europepmc]
Related